Covid-19 roundup: FDA addresses risk of excessive bleeding after J&J vaccine; Novavax vaccine gets OK in South Korea
The FDA has added a new risk to the fact sheet for J&J’s Covid-19 vaccine: immune thrombocytopenia, a condition that can lead to easy or …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
